Henry Meds vs Fella Health: Medication Options and Pricing Compared

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic factors behind every metabolic decision. Browse all Peptides & GLP-1 education.

Two programs, two ways of getting a prescription to you

People searching for a Henry Meds and Fella Health comparison usually want one thing settled: which medications each program actually puts in your hands, and what that costs. Both operate in the crowded GLP-1 telehealth market, and as of April 2026 they sit among dozens of comparable services. This is a medication-focused read, not a verdict — the right fit depends on your clinician, your eligibility, and your budget.

Full head-to-head: PlexusDx vs Henry Meds →

Independent editorial note: PlexusDx runs no partnership, affiliate arrangement, or paid placement with Henry Meds or Fella Health. Nothing here is sponsored.

How Henry Meds dispenses medication

Henry Meds pairs virtual clinical evaluation with compounded-pharmacy fulfillment. In this model a licensed provider reviews an intake, and — where eligibility is met — writes a prescription that routes to a licensed compounding pharmacy for a compounded GLP-1, or to retail for an FDA-approved brand product where that path applies. Current program details live on Henry Meds's official website.

How Fella Health approaches treatment

Fella Health markets a men-focused telehealth experience. Its medication menu, provider mix, and subscription mechanics change over time, so the reliable source is Fella Health's official website at the moment you read this. What both brands share is that neither one manufactures the compound — the pharmacology comes from the molecule, not the storefront.

The compound decides the biology, not the brand

Every legitimate program in this space prescribes the same underlying classes: GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and GIP/GLP-1 dual agonists (tirzepatide). These act on appetite regulation, satiety signaling, and gastric emptying. The evidence base sits with the molecules, not the platforms — STEP studied semaglutide for weight management (NEJM 2021), SURMOUNT studied tirzepatide (NEJM 2022), and SURMOUNT-OSA looked at tirzepatide in obstructive sleep apnea (NEJM 2024). Effect sizes shift by compound, dose, and person.

Henry Meds's published pricing ladder

Henry Meds prices per medication and advertises a low headline figure that assumes twelve months paid up front; its month-to-month number is higher. Here is Henry's ladder as published, each figure labeled (verified July 20, 2026):

• Injectable compounded semaglutide (the flagship): $297/month month-to-month. Prepaid plans lower it — the 6-month plan is $1,482 ($247/month) and the 12-month plan is $2,364 ($197/month). Henry's advertised “$197/month” is that 12-month prepaid-in-full rate, not a month-to-month price.
• Oral (sublingual) semaglutide: $249/month month-to-month, with a $179/month tier.
• Oral tirzepatide: dissolving tablets only — Henry does not offer an injectable tirzepatide as of July 2026. It is sold as a 3-month supply at $1,047 ($891 paid in full); Henry publishes no month-to-month tirzepatide rate.
• Liraglutide (injectable): $179/month month-to-month.
• Phentermine (oral): $149/month.

Henry charges no membership fee and no per-visit consultation fee — the provider evaluation is free, nothing is billed until a prescription is written, and the subscription bundles medication, supplies, shipping, and ongoing care. Its refund policy is not stated. Fella Health publishes its own rates on its site; rather than repeat a figure that may be stale, confirm Fella's current pricing directly. Re-check Henry's numbers on Henry Meds's official website before deciding.

The genetic layer neither prescription captures

Whichever brand writes the script, the prescription says nothing about the genetics underneath your response. Variants in FTO (fat-mass and obesity-associated), GLP1R (the GLP-1 receptor itself), MC4R (a satiety and energy-balance receptor), and TCF7L2 (tied to glucose handling and GLP-1 secretion) describe the metabolic terrain a clinician is prescribing into. They are pathway-level markers — they do not predict how you will respond to any single drug. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols, and the Precision Peptide Genetic Test maps 14 pathways, 49 peptides, 150+ genetic insights — the upstream context to bring into a conversation with your own provider before you commit.

No affiliation: PlexusDx has no commercial relationship with Henry Meds, Fella Health, or any brand named in this review.

Related reading on PlexusDx: GLP 1 Hormone, What Is GLP 1, GLP 1 What Is, GLP 1 Receptor Agonist.

Editorial disclaimer: This comparison is educational and independent. PlexusDx sells semaglutide and tirzepatide through its own Weight Management Protocols and is not affiliated with the brands reviewed. The Precision Peptide Genetic Test reflects how your genes influence peptide-related pathways — it does not predict response to any specific medication. Talk with a licensed provider before starting any protocol.

Frequently Asked Questions

Which program offers injectable tirzepatide, Henry Meds or Fella Health?

As of July 2026 Henry Meds lists tirzepatide only as dissolving tablets, not an injectable, per its published catalog. Fella Health's medication menu changes and is documented on its own site. Confirm current injectable availability with each brand directly before assuming either offers it.

Why is Henry Meds's advertised price lower than the monthly cost?

Henry's headline semaglutide figure of $197/month reflects a twelve-month plan paid in full up front, not a rolling monthly charge. The true month-to-month rate for injectable compounded semaglutide is $297. Prepaid commitment buys the discount, so read which tier a quoted price belongs to.

Does either program bill a separate consultation fee?

Henry Meds states it charges no membership or per-visit fee, with the provider evaluation free and nothing billed until a prescription is written. Fella Health publishes its own fee structure. Because policies change, verify consultation and cancellation terms on each brand's site before enrolling.

Can a genetic test tell me which program's medication will work?

No. The Precision Peptide Genetic Test does not predict drug response or rank telehealth programs. It reports pathway-level variants in genes such as FTO, and MC4R that describe your baseline metabolic biology — context that applies no matter which brand ultimately writes the prescription.

Continue learning in the PlexusDx Education Hub. Browse all Peptides & GLP-1 education.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.